- Open
- 0.95
- High
- 1.00
- Low
- 0.91
- Close
- 0.99
- Change
- -0.05 (-5.26%)
- Volume
- 3,532,754
| 28 Aug 2026 | 07:00:03 | CARDIO inCode-Score milestone clinical results |
| 1 Jul 2026 | 13:30:58 | Result of AGM |
| 11 Jun 2026 | 17:42:33 | Holding(s) in Company |
| 10 Jun 2026 | 16:53:21 | Holding(s) in Company |
| 8 Jun 2026 | 07:00:06 | Final Results |
| 18 Aug 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 10 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 8 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
Genincode plc develops and commercializes genetic testing solutions aimed at assessing the risk of cardiovascular disease. The company offers a range of products, including genetic testing kits and laboratory testing services, which utilize genetic and clinical data to provide healthcare professionals with insights for patient risk assessment. Genincode operates primarily in the healthcare sector, serving hospitals, clinics, and healthcare providers, with a focus on markets in the United Kingdom and the United States.
| 28 Aug 2026 | 07:00:03 | CARDIO inCode-Score milestone clinical results |
| 1 Jul 2026 | 13:30:58 | Result of AGM |
| 11 Jun 2026 | 17:42:33 | Holding(s) in Company |
| 10 Jun 2026 | 16:53:21 | Holding(s) in Company |
| 8 Jun 2026 | 07:00:06 | Final Results |
| 18 Aug 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 10 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 8 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
Genincode plc develops and commercializes genetic testing solutions aimed at assessing the risk of cardiovascular disease. The company offers a range of products, including genetic testing kits and laboratory testing services, which utilize genetic and clinical data to provide healthcare professionals with insights for patient risk assessment. Genincode operates primarily in the healthcare sector, serving hospitals, clinics, and healthcare providers, with a focus on markets in the United Kingdom and the United States.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £451m | -0.4% | |
| £18m | -0.1% | |
| £14m | +2.1% | |
GENIGenincode plc | £3m | -0.3% |
| £1m | -1.0% | |
| £361k | -0.8% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £451m | -0.4% | |
| £18m | -0.1% | |
| £14m | +2.1% | |
GENIGenincode plc | £3m | -0.3% |
| £1m | -1.0% | |
| £361k | -0.8% |
